| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |